1. Introduction {#sec1-genes-08-00238}
===============

The genus *Angelica*, which includes more than 60 species, is an important medicinal herb in Far East countries, especially in Korea, Japan, and China. Many of these species have been used in traditional medicine to treat many diseases in Asian and Western countries \[[@B1-genes-08-00238]\]. *Angelica* species that grow naturally in South Korea, beside *Angelica gigas* Nakai, include *Angelica acutiloba* Kitagawa, *Angelica archangelica* L., *Angelica atropurpurea* L., *Angelica dahurica* (Fisch. ex Hoffm.) Benth. & Hook. f. ex Franch. & Sav., *Angelica decursiva* (Miq.) Franch. & Sav., *Angelica genuflexa* Nutt. ex Torr. & A. Gray, *Angelica glauca* Edgew., *Angelica jaluana* Nakai, *Angelica japonica* A. Gray, *Angelica koreana* L., *Angelica sinensis* Diels, *Angelica sylvestris* L., and others.

The root of *A. gigas* contains active compounds, such as decursin, and decursinol angelate \[[@B2-genes-08-00238]\], which is successfully used in treating gynecological and anemic health issues \[[@B3-genes-08-00238],[@B4-genes-08-00238]\]. They are also used for inducing immune system, and for constipation relief \[[@B1-genes-08-00238],[@B5-genes-08-00238]\]. Herbalists consider it equivalent to ginseng due to its remedial properties for several diseases including treating cancer \[[@B6-genes-08-00238]\], an anti-oxidant \[[@B7-genes-08-00238]\], neuro-protective, anti-flu, anti-hepatitis \[[@B1-genes-08-00238]\], and anti-bacterial activities \[[@B8-genes-08-00238]\]. The *A. gigas* root also contains important chemical compounds like pyranocoumarins, essential oils, and poly-acetylenes.

Due to the scarcity of efficient molecular markers, there is a dearth of information about the genetic relationships and genetic diversity among breeding populations of *Angelica* crops \[[@B9-genes-08-00238]\]. Thus, to address these issues, during the past 30 years many kinds of markers have been developed and used for crop genetics and breeding \[[@B10-genes-08-00238]\]. The improvement in DNA sequencing and genotyping in conjunction with the development of computer programs have helped the design of molecular markers such as simple sequence repeats (SSRs) in minor crops \[[@B11-genes-08-00238]\].

Molecular markers are widely used in various areas such as genetic-diversity characterization, gene-flow studies, quantitative-trait locus (QTL) mapping, and evolutionary studies \[[@B12-genes-08-00238]\]. Accumulated plant genome sequences have accelerated single nucleotide polymorphism (SNP) marker development. Numerous SNP markers have been successfully used to develop various crop cultivars \[[@B13-genes-08-00238]\]. However, SNP marker technology requires special equipment and it is costly. In contrast, SSR markers are very convenient and easy to use. SSR markers are tandemly repeated nucleotide sequence motifs \[[@B14-genes-08-00238]\]; that are dispersed throughout the genome and may exhibit locus-specific codominance and high polymorphism rates, and have a high level of transferability \[[@B15-genes-08-00238],[@B16-genes-08-00238],[@B17-genes-08-00238]\]. Furthermore, molecular markers can be used to distinguish cultivars or plants originating from different locations. SSR markers are effective tools that play an important role in plant cultivar identification and genetic diversity analysis \[[@B18-genes-08-00238]\]. The next generation sequencing (NGS) technologies can be used for fast and cost-effective SSR discovery in many crops \[[@B19-genes-08-00238]\].

The *Angelica* species used in conventional medicine varies by country according to specific regulations, i.e., *A. gigas* in Korea, *A. sinensis* in China, and *A. acutiloba* in Japan. Because of the similarity between the names among *Angelica*, they can be confused in the market \[[@B20-genes-08-00238]\]. SSR markers are especially useful to distinguish closely related genotypes. This is the reason that SSR markers are widely used in genetic studies and identification of closely related cultivars. By using these SSR markers, various problems of *Angelica* genus can be solved \[[@B21-genes-08-00238]\].

In this study, we developed polymorphic SSR markers from several *A. gigas* accessions using NGS and bioinformatics approaches. The SSR markers developed in this study could be used for genetics and the breeding of *Angelica* genus.

2. Material and Methods {#sec2-genes-08-00238}
=======================

2.1. Plant Material and DNA Isolation {#sec2dot1-genes-08-00238}
-------------------------------------

Sixteen widely cultivated *A. gigas* accessions were collected in Korea ([Table S1](#app1-genes-08-00238){ref-type="app"}). All of the collected roots or seeds were germinated and grown in the Chungbuk National University greenhouse. Young leaves or fresh seedlings were used for extraction of the genomic DNA (gDNA), which is required for library construction and sequencing. Fresh leaves were ground with liquid nitrogen and DNA was extracted using a DNeasy Plant Mini kit (Qiagen, Valencia, CA, USA) according to the manufacturer's instructions.

2.2. Genomic DNA Sequencing and Sequence Assembly {#sec2dot2-genes-08-00238}
-------------------------------------------------

The libraries were constructed from five *A. gigas* accessions: Manchu variety (MV), Hwangje variety (HV), Gangwon local variety (GLV), Jecheon local variety (JLV), and Sancheong local variety (SLV). Sequencing size was one lane for MV and 1/3 lane for the other four varieties. Sequencing libraries for DNA samples were prepared by a TruSeq Nano DNA Sample Prep Kit, according to the manufacturer\'s instructions (Illumina, Inc., San Diego, CA, USA). The libraries were subjected to paired-end sequencing with a 101 bp read length using the Illumina HiSeq 2500 platform (Illumina). Errors of short reads for each sample were corrected by using the SOAPec part of SOAPdenovo2 version 2.04 \[[@B22-genes-08-00238]\]. After error correction, short reads corresponding to ≥13× of genome size, estimated on the basis of a *k*-mer frequency spectrum, were assembled by using SOAPdenovo2 with the adjustment of *k*-mer size of 53. Repetitive DNA sequences, such as microsatellites, transposable elements, and rDNAs, were screened in the assembled contigs by using RepeatMasker version 4.0.5 \[[@B23-genes-08-00238]\] and RepeatModeler version 1.0.8 \[[@B23-genes-08-00238]\]. From the resulting repeat-masked sequences, gene models were built by ab initio prediction coupled with transcript alignment using AUGUSTUS version 3.1 \[[@B24-genes-08-00238]\], with the training gene set derived from the genome of *Platycodon grandiflorum* (unpublished), which belongs to the subclass Asterids. Genes were searched against UniProt and NCBI non-redundant (NR) protein databases using BLASTX, with a cutoff *E*-value of 10^−10^. Protein domains in genes were searched by using InterProScan version 5.17-56.0 \[[@B25-genes-08-00238]\].

2.3. SSR Findings and Primer Designs {#sec2dot3-genes-08-00238}
------------------------------------

Simple sequence repeats were identified by using SSR Finder \[[@B26-genes-08-00238]\] with the following parameters: (1) microsatellites consisting of tandem repeats of 2 to 10 bp with a minimum of five repeats; and, (2) no variation (mutation) in repeat motifs was permitted. Primers were designed from flanking sequences of SSR microsatellite loci by using Primer3 version 2.2.3 \[[@B27-genes-08-00238]\] with the following parameters: primer length = 18--26 bp (Opt. 23 bp); GC % = 50--70% (Opt. 60%); temperature = 55--62 °C (Opt. 58 °C); and, product size range = 150--200 bp. Repetitive DNA, as well as duplicate sequences, were excluded and selected primers from the unique genomic regions. Forward primers were labeled with a virtual dye 6-FAM, NED, VIC, or PET (Applied Biosystems, Foster City, CA, USA).

2.4. In Silico SSR Polymorphism Screening {#sec2dot4-genes-08-00238}
-----------------------------------------

In silico SSR polymorphism screening was performed by using CLC Main Workbench version 6.8.4 (CLC bio, Aarhus, Denmark) BLAST tool. HV, GLV, JLV and SLV sequences were assembled by using CLC Genomics Workbench version 7.5 (CLC bio, Aarhus, Denmark) and prepared for BLAST data base. The SSR regions (450 bp each) identified from MV sequences were used as reference sequences in a BLAST search. BLAST analyses were performed by the following parameters: BLAST program = blastn: DNA sequence and database; Target = BLAST database (HV, GLV, JLV and SLV sequences); Number of threads = 1; Choose filter = Filter low complexity; Expect = 10.0; Word size = 3; Match/mismatch cost = match 1, mismatch −3; Gap costs = Existence 5, Extension 2; and, Max number of hit sequences = 250 ([Figure S1](#app1-genes-08-00238){ref-type="app"}).

2.5. PCR Amplification and Genotyping {#sec2dot5-genes-08-00238}
-------------------------------------

The PCR reaction mixture (20 μL) consists of 20 ng of gDNA, 1× HSTM Taq DNA polymerase buffer, 1.5 mM MgCl2, 0.2 mM of each dNTP, 0.2 M of each primer, and 1.25 units HSTM Taq DNA polymerase (Dongsheng, Göttingen, Germany). DNA amplification was performed by using the PCR system (BIO-RAD T-100 Thermal Cycler) according to the following: 5 min for initial denaturation at 95 °C, 34 cycles of 30 s at 94 °C, 30 s at 58--60.5 °C, 30 s at 72 °C, concluding with 1 cycle of 30 min at 72 °C. PCR products were separated in a 4% agarose gel to check the amplification and 0.2 L of PCR products were mixed with 9.8 L Hi-Di formamide (Applied Biosystems, Foster City, CA, USA), and 0.2 L of GeneScanTM 500 LIZ^®^size standard (Applied Biosystems). The PCR product mixture was denatured at 95 °C for 5 min and kept on ice. Subsequently, the mixture was separated by capillary electrophoresis on the ABI 3730 DNA analyzer (Applied Biosystems) by using a 50 cm-capillary array with a DS-33 install standard as a matrix. We analyzed the amplified fragments by size with GeneMapper software version 4.0 (Applied Biosystems). The number of alleles (*N~A~*), frequency of major alleles (*M~AF~*), observed heterozygosity (*H~O~*) values, expected heterozygosity (*H~E~*) values, and polymorphic index content (PIC) values were measured by using PowerMarker software version 3.23 \[[@B28-genes-08-00238]\]. Coefficients of genetic similarity were calculated by using the molecular evolutionary genetics analysis (MEGA) program version 5.05 \[[@B29-genes-08-00238]\]. Genetic distance was computed by using the SharedAllele distance method with PowerMarker software version 3.23.

3. Results and Discussion {#sec3-genes-08-00238}
=========================

3.1. Characteristics of Genomic SSR in the NGS Assemblies of A. gigas {#sec3dot1-genes-08-00238}
---------------------------------------------------------------------

Libraries were constructed from the five *A. gigas* accessions ([Table 1](#genes-08-00238-t001){ref-type="table"}) and subjected to paired-end sequencing with a 101 bp read length by using an Illumina HiSeq 2500 platform. The SOAPdenovo2 assembler (version 2.04) was used to assemble the *A. gigas* genome de novo, generating 395,007 scaffolds representing 804 Mb from the *A. gigas* (MV) genome. MV is a breed that was developed based on the root hypertrophy and slow-bolting characteristic from *A. gigas*. Thus, we selected MV as a representative *A. gigas* variety. The other four varieties were selected due to their diverse geographical origins. The four varieties were used for in silico polymorphism analysis. Analysis of *k*-mer frequency spectrum revealed a peak (*k*-mer depth: 11) in the 17 *k*-mer depth distribution of reads, suggesting a low heterozygosity across the genome ([Figure S2](#app1-genes-08-00238){ref-type="app"}). Based on the *k*-mer frequency analysis, the genome size of MV was estimated to be approximately 2.67 Gb (No. of *k*-mer/depth of *k*-mer at peak). Conclusively, we found, 138,113 SSRs from the de novo assembly of the MV genome. The total number of 121,112 di-nucleotide, and 13,211 tri-nucleotide SSRs constituted 87.691% and 9.565% of SSRs, respectively, followed by tri-, tetra-, penta- and hexa-nucleotide motifs ([Table S2](#app1-genes-08-00238){ref-type="app"}).

3.2. SSR Marker Development by In Silico Polymorphism Analysis and Characterization of SSR Markers {#sec3dot2-genes-08-00238}
--------------------------------------------------------------------------------------------------

We successfully designed 16,496 SSR primer pairs, out of 138,113 SSRs from the unique genomic regions of MV genome assembly. The majority of designed SSR primer sets was di-nucleotide (14,113, in SSR, 10.218%), followed by tri-nucleotide (2064, in SSR, 1.494%), tetra-nucleotide (242, in SSR, 0.175%), penta-nucleotide (36, in SSR, 0.026%), and hexa-nucleotide (37, in SSR, 0.027%) motifs ([Table S2](#app1-genes-08-00238){ref-type="app"}). Initially, five *A. gigas* accessions (MV, HV, GLV, JLV, and SLV) were selected to detect the polymorphism of these primer sets by in silico analysis.

The MV scaffolds including the SSRs were subjected to BLAST analysis against the assembled contigs of four other varieties (HV, GLV, JLV, and SLV). Polymorphic SSR markers showed two to five different repeat length scaffolds from the five *A. gigas* accessions. Consequently, a total of 848 polymorphic SSR markers were selected from the in silico analyzed tri-nucleotide to hexa-nucleotide motifs (a total of 2379 SSR primer sets).

We selected 48 polymorphic SSR markers, from 848 in silico analyzed primer pairs, which were showing four or more different repeat length scaffolds types, or more than 15 bp of nucleotide length difference ([Table S2](#app1-genes-08-00238){ref-type="app"}; [Figure S1](#app1-genes-08-00238){ref-type="app"}) and further used for genotyping of five *A. gigas* accessions (MV, HV, GLV, JLV, and SLV). Thirty-six SSR primer sets yielded balanced, intact, reproducible, and polymorphic amplicons in 4% agarose gels. The remaining 12 SSR primer sets were amplified more than two bands or showed unexpected amplicon sizes. The 36 SSR primer sets were deposited to GenBank ([Table 2](#genes-08-00238-t002){ref-type="table"}). Genomic regions of the 36 SSR loci were also analyzed on the basis of ab initio gene identification in the assembled sequences, and 16 (44.4%), 9 (25.0%), 9 (25.0%), and 2 (5.6%) were found from intergenic, intron, coding DNA sequence (CDS), and 5′ untranslated region (5\'UTR), respectively ([Table S3](#app1-genes-08-00238){ref-type="app"}).

Subsequently, 16 *A. gigas* accessions were used to detect the polymorphisms of the 36 SSR loci after one of the primers from each primer set was labeled. Polymorphism estimation indicated that the *N~A~* per locus varied widely among the markers, ranging from 3 to 15, with an average of 6.36 alleles. The *M~AF~* per locus was 0.16--0.63, with an average of 0.39. In addition, the *H~E~* values were 0.53--0.90, with an average of 0.73; *H~O~* values were 0.13--0.88, with an average of 0.53. Ultimately, PIC values were 0.44--0.89, with an average of 0.69 ([Table 3](#genes-08-00238-t003){ref-type="table"}). Thirty-six SSR markers showed a high PIC value (PIC \> 0.6) and, based on our results, we constructed the genetic relationship of 16 *A. gigas* accessions. Phylogenetic trees were constructed for the 16 *A. gigas* accessions by unweighted pair group method with arithmetic mean (UPGMA) analysis ([Figure S3](#app1-genes-08-00238){ref-type="app"}).

The study of genetic diversity and genetic relationships of crops can assist breeders in the development of economically effective cultivars. SSR markers have been used in many areas, including linkage map development, QTL mapping, marker-assisted selection, cultivar fingerprinting, genetic diversity, gene flow, and evolutionary studies in the botanic sciences \[[@B30-genes-08-00238],[@B31-genes-08-00238],[@B32-genes-08-00238]\]. NGS technology is a modern technique used to discover large-scale genetic polymorphisms \[[@B32-genes-08-00238],[@B33-genes-08-00238],[@B34-genes-08-00238]\]. Since NGS technology allows cost-effective and higher throughput genome sequencing, it has been universally applied for many crop species, including *Allium fistulosum* L., *Sesamum indicum* L., and *Vicia sativa* subsp. *Sativa* \[[@B35-genes-08-00238],[@B36-genes-08-00238]\]. Recently, a study on the development of 18 polymorphic microsatellite markers for *A. sinensis* using NGS technology has been reported although it was focused on species identification \[[@B37-genes-08-00238]\]. In this study, we developed SSR markers that could be used for genetics, breeding, and diversity analyses of *Angelica* species.

The selection of isolated SSR loci from the genome or transcriptome data would be useful to analyze data, project goals, and future plans \[[@B34-genes-08-00238]\]. Our mass production method of SSR markers using an in silico approach, and resulted in 36 new polymorphic SSR markers from *A. gigas*. The developed markers from this study are expected to be useful in crop genetics and breeding. Even though the remaining 12 SSR markers amplified multiple bands or yielded bands of unexpected size, they were also polymorphic in the sequence. Therefore, the 848 SSR marker candidates discovered through this research are expected to represent informative markers.

Even though we restricted the purpose of this study on the selection of polymorphic SSR markers for the genetic diversity analysis of the genetic resources, application of the primers to more diverse *Angelica* species resources can enlarge the usage of the developed markers. In addition, we hope that the *A. gigas* sequence data of this study can be used to develop various molecular markers, such as SNP and insertion-deletion (InDel) markers, in the future.
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genes-08-00238-t001_Table 1

###### 

Genome sequencing of five *Angelica gigas* accessions.

                               MV               HV               GLV              JLV              SLV
  ---------------------------- ---------------- ---------------- ---------------- ---------------- ----------------
  Total Reads                  351,885,410      153,890,676      112,354,576      139,011,848      142,791,294
  Total Bases                  35,540,426,410   15,542,958,276   11,347,812,176   14,040,196,648   14,421,920,694
  Number of Scaffolds          395,007          541,229          468,810          526,114          546,442
  Assembled genome size (bp)   804,583,850      298,362,936      242,460,776      273,337,815      298,605,080

MV, Manchu variety; HV, Hwangje variety; GLV, Gangwon local variety; JLV, Jecheon local variety; SLV, Sancheong local variety.

genes-08-00238-t002_Table 2

###### 

Characterization of 36 polymorphic single sequence repeat (SSR) markers validated in 16 *A. gigas* accessions.

  Marker                           GenBank No.   Motif        Primer Sequence                Annealing Temperature (°C)   Allele Size (bp)
  -------------------------------- ------------- ------------ ------------------------------ ---------------------------- ------------------
  YL-AGN tri0110                   KX138563      (AAT) 5      F:FAM-TATGTCGGCAACACATGC       58                           177--186
  R:GTTTGGCTAGGCTAGACTAATGTGGGT                                                                                           
  YL-AGN tri0221                   KX138564      (ACC) 7      F:FAM-CGACACCAGTGTTGATCCAT     58                           179--194
  R:GTTTGTATCGAGTCCATAACGCTCAG                                                                                            
  YL-AGN tri0303                   KX138565      (AGC) 5      F:FAM-AGGCGATAGAATCCCCAA       58                           157--175
  R:GTTTCGAGAAACAAAGCTTCAGGG                                                                                              
  YL-AGN tri0336                   KX138566      (AGG) 8      F:FAM-GTGGTGTTCTTTTCTCCACG     58                           185--203
  R:GTTTCTTGTCGTCTTCTCGTCTCTCT                                                                                            
  YL-AGN tri0359                   KX138567      (AGT) 8      F:FAM-CGTCGGCTAGTAACTGCAAA     58                           188--194
  R:GTTTATGTCGCGGTGATTTACG                                                                                                
  YL-AGN tri0379                   KX138568      (ATA) 15     F:FAM-GCTGTTCTGGCGTATGTACTTC   58                           161--191
  R:GTTTACTCCCAACAAACACTGCTC                                                                                              
  YL-AGN tri0537                   KX138569      (ATG) 7      F:FAM-GGTCCTCAGCTTTCTCAGAATC   58                           175--217
  R:GTTTCCTGATATCTCCCTGCAATC                                                                                              
  YL-AGN tri0638                   KX138594      (ATT) 7      F:PET-AGCATAGGATCCAGCTTGTG     58                           134--161
  R:GTTTTTTCGAGATGGAGTCTCAGC                                                                                              
  YL-AGN tri0685                   KX138570      (CAC) 5      F:FAM-AGTAAGCAAGTGATGCCGAG     58                           179--197
  R:GTTTGGGGGTTTTGTAGTGGTTCA                                                                                              
  YL-AGN tri0832                   KX138571      (CCA) 5      F:FAM-CCACTTTACTCCCCTGATAAGC   58                           163--184
  R:GTTTTTCCTGCCAGCTCTGATTAC                                                                                              
  YL-AGN tri0861                   KX138572      (CCT) 5      F:NED-CTGGTGGCTCTTAAGTTACTCG   58                           193--230
  R:GTTTCGGTTACTACAGTACGTTGGTTGC                                                                                          
  YL-AGN tri0889                   KX138573      (CCT) 5      F:NED-GACAAAGAAGCAGTGGCATC     58                           193--202
  R:GTTTGAGATTACGACGAGCGAGAA                                                                                              
  YL-AGN tri0953                   KX138595      (CTG) 16     F:PET-TGTTTGCACCAGCTCTCA       58                           180--209
  R:GTTTCCACCTCAAGGTTCAATGAC                                                                                              
  YL-AGN tri0955                   KX138596      (CTG) 9      F:PET-TAGCCAAGACCAGCTCAATC     58                           144--167
  R:GTTTTACTGCTACAATGGCACACC                                                                                              
  YL-AGN tri0957                   KX138574      (CTG) 6      F:NED-CAGTTCCGTTGTTCCAACTC     58                           188--203
  R:GTTTGAAAGCGAACGAGAGATGAG                                                                                              
  YL-AGN tri1043                   KX138575      (GAA) 8      F:NED-GCTGGATTATCACCTTCACG     58                           191--204
  R:GTTTGAAGAGGTAATGTGGGGTGTAG                                                                                            
  YL-AGN tri1092                   KX138597      (GAA) 14     F:PET-CTAGCTTTCCCATGTCTGAACC   58                           143--201
  R:GTTTCATCCATGCACCAATGTC                                                                                                
  YL-AGN tri1102                   KX138576      (GAC) 5      F:NED-ACTCAAAAGGACAAGTCCCC     58                           150--200
  R:GTTTCCTTCCACTCTCTGGTTGTAGAC                                                                                           
  YL-AGN tri1118                   KX138577      (GAG) 5      F:NED-AACTGATTGGGAGGAGTAGGAG   58                           168--183
  R:GTTTCCTGAAAGAGTACTAACACCCG                                                                                            
  YL-AGN tri1174                   KX138578      (GAT) 6      F:NED-AGCAACTAGCTCACTCACAACC   58                           196--210
  R:GTTTAGACGAGTTAAGGGACTTGC                                                                                              
  YL-AGN tri1211                   KX138579      (GCA) 8      F:NED-ATGCAACAATGTCTCGGC       58                           162--180
  R:GTTTCAACTTGGGTTCTGCCCTAT                                                                                              
  YL-AGN tri1262                   KX138580      (GCT) 7      F:NED-GTTACATTGAGTCCTCGTAGGG   58                           171--199
  R:GTTTATCACGAACCAGAACCCA                                                                                                
  YL-AGN tri1269                   KX138581      (GCT) 5      F:VIC-CCCTTGACACTCACTACTCTCA   58                           202--217
  R:GTTTTTCTCTCTGCTACCCTTAGAGC                                                                                            
  YL-AGN tri1276                   KX138598      (GCT) 5      F:PET-GATTGCTGCTGCTGAGTTG      58                           156--177
  R:GTTTGAACTCTCCGATGGTGTTGTAG                                                                                            
  YL-AGN tri1358                   KX138582      (GTA) 6      F:VIC-GACAGCCAGCCTTCTTCAT      58                           182--194
  R:GTTTCCCTACATTGCGTTGATCC                                                                                               
  YL-AGN tri1582                   KX138583      (TCA) 8      F:VIC-GGTACGGGAATATGAGACAGG    58                           183--206
  R:GTTTGTGATCTTGCTGATGACGG                                                                                               
  YL-AGN tri1708                   KX138584      (TCT) 10     F:VIC-GTGGTGCTGCCAATGTTT       58                           172--241
  R:GTTTGAAGATGTCGGCAGATCAGT                                                                                              
  YL-AGN tri1849                   KX138585      (TGG) 7      F:VIC-GTCCAATGATTCTGCTGCTC     60.5                         174--183
  R:GTTTATATACTGGGAGTGTTGCGGAG                                                                                            
  YL-AGN tri1920                   KX138586      (TTA) 8      F:VIC-TACAGTCGAGTTCTGGACACAC   58                           179--200
  R:GTTTCTTTCTCCGTGAACATGTCG                                                                                              
  YL-AGN tetra2116                 KX138587      (AGAT) 9     F:VIC-GTCACTAAAACACGAGACTGCC   58                           179--250
  R:GTTTCCAGAACTCGTTCCGAATC                                                                                               
  YL-AGN tetra2173                 KX138588      (ATTT) 5     F:VIC-AGGCATGCACTACTCCTCTATC   58                           179--191
  R:GTTTATCTCGCAGCTATGAGACTACC                                                                                            
  YL-AGN tetra2208                 KX138589      (GATA) 6     F:VIC-GCTGGGTTTAGGTTTCTGGA     60.5                         157--177
  R:GTTTACCGCAAACACCTAGTACTCC                                                                                             
  YL-AGN tetra2275                 KX138590      (TGTA) 7     F:PET-CATCATCTTGCAAGGTCCAC     58                           164--188
  R:GTTTTCTCCCAAACTGGTACTCTG                                                                                              
  YL-AGN Hexa2350                  KX138591      (AGAATC) 6   F:PET-GCTAGCAATAGCAGGTTGAC     58                           193--210
  R:GTTTATAGACCTGGTTTCGGGC                                                                                                
  YL-AGN Hexa2367                  KX138592      (GATCTC) 5   F:PET-ACGTGACCACCATATTGC       58                           187--199
  R:GTTTGTGGACACTGTTTCGTCACTG                                                                                             
  YL-AGN Hexa2374                  KX138593      (TCATGC) 5   F:PET-GGCAGACGTTCTGGTTTTC      58                           164--176
  R:GTTTCCGTGAGTGGTAGGGAAATA                                                                                              

genes-08-00238-t003_Table 3

###### 

Diversity statistics from initial primer screening in 16 *A. gigas* accessions.

  No.   Marker            *M~AF~*   *N~G~*   *N~A~*   *H~E~*   *H~O~*   PIC
  ----- ----------------- --------- -------- -------- -------- -------- ------
  1     YL-AGNtri0110     0.47      7        4        0.68     0.67     0.63
  2     YL-AGNtri0221     0.25      11       6        0.80     0.63     0.77
  3     YL-AGNtri0303     0.50      8        5        0.67     0.50     0.62
  4     YL-AGNtri0336     0.34      11       5        0.77     0.50     0.73
  5     YL-AGNtri0359     0.57      4        3        0.56     0.33     0.48
  6     YL-AGNtri0379     0.28      10       7        0.78     0.44     0.75
  7     YL-AGNtri0537     0.53      9        7        0.67     0.56     0.64
  8     YL-AGNtri0638     0.33      9        5        0.75     0.40     0.71
  9     YL-AGNtri0685     0.44      10       7        0.73     0.69     0.70
  10    YL-AGNtri0832     0.38      8        7        0.76     0.19     0.73
  11    YL-AGNtri0861     0.31      9        10       0.84     0.50     0.82
  12    YL-AGNtri0889     0.59      4        3        0.53     0.19     0.44
  13    YL-AGNtri0953     0.31      13       10       0.82     0.75     0.81
  14    YL-AGNtri0955     0.44      8        5        0.72     0.69     0.68
  15    YL-AGNtri0957     0.31      9        5        0.75     0.44     0.71
  16    YL-AGNtri1043     0.63      7        5        0.56     0.44     0.52
  17    YL-AGNtri1092     0.22      15       11       0.87     0.63     0.86
  18    YL-AGNtri1102     0.34      11       8        0.79     0.44     0.77
  19    YL-AGNtri1118     0.34      9        4        0.71     0.69     0.66
  20    YL-AGNtri1174     0.38      9        5        0.71     0.31     0.66
  21    YL-AGNtri1211     0.41      10       6        0.75     0.50     0.71
  22    YL-AGNtri1262     0.31      10       8        0.80     0.88     0.77
  23    YL-AGNtri1269     0.50      8        6        0.68     0.75     0.64
  24    YL-AGNtri1276     0.25      13       8        0.84     0.56     0.82
  25    YL-AGNtri1358     0.47      9        5        0.67     0.44     0.62
  26    YL-AGNtri1582     0.31      11       8        0.82     0.75     0.80
  27    YL-AGNtri1708     0.16      14       14       0.90     0.50     0.89
  28    YL-AGNtri1849     0.63      3        4        0.54     0.13     0.48
  29    YL-AGNtri1920     0.31      13       8        0.81     0.75     0.79
  30    YL-AGNtri2275     0.41      9        6        0.73     0.69     0.69
  31    YL-AGNtetra2116   0.22      13       14       0.88     0.75     0.87
  32    YL-AGNtetra2173   0.41      8        4        0.69     0.75     0.63
  33    YL-AGNtetra2208   0.41      7        5        0.67     0.25     0.61
  34    YL-AGNhexa2350    0.44      7        4        0.64     0.56     0.57
  35    YL-AGNhexa2367    0.46      6        4        0.64     0.38     0.57
  36    YL-AGNhexa2374    0.44      6        3        0.63     0.44     0.56
        Mean              0.39      9.1      6.4      0.73     0.53     0.69

*M~AF~*, major allele frequency; *N~G~*, number of genotypes; *N~A~*, number of alleles; *H~E~*, expected heterozygosity; *H~O~*, observed heterozygosity; PIC, polymorphism information content.

[^1]: These authors contributed equally to this work.
